Chemical Week Magazine :: Pharmaceuticals & Fine Chemicals
Cambrex’s Sales and Profits Rise
11:24 AM MDT | July 27, 2007 | Chemical Week Editorial Staff
Cambrex says its fourth-quarter 2006 operating profits increased 3%, to $13 million, on sales up 7% to $66 million, benefiting from a 5% positive currency impact. Gross margins decreased, however, to 33.4%, from 35.3%, primarily due to pricing pressures on certain active pharma ingredients (API) and increased production costs. Full-year operating profits declined 4%, to $49 million, on sales up 6%, to $237 million. The annual results reflect an increase in the number of custom development projects and greater demand for generic APIs, which was partially offset by...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee